Physician

Adam J Lish, MD

According to 2025 Medicare claims, Adam Lish, MD (NPI: 1083711766) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Kings, NY. This provider's primary affiliated billing organization is BROOK PLAZA OPTHALMOLOGY ASSOC PC (NPI: 1093939001) and primary practice location at 11234-3225.

Lish's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 449 traditional Medicare patients, billed 3,124 HCPCS/CPT codes, and received $265,564 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 4,324 prescription claims across 1,010 beneficiaries totaling $551,420 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 12 records totaling $342. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have declined steadily, from $753,812 to $551,420. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$138K$276K2015 Medicare payment: $243,390 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $188,177 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $188,506 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $207,660 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $252,669 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $179,335 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $226,502 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $274,189 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $275,957 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $265,564 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156942,622$243,390
20165342,105$188,177
20174372,165$188,506
20184732,739$207,660
20194913,176$252,669
20204702,569$179,335
20214742,840$226,502
20224203,343$274,189
20234543,265$275,957
20244493,124$265,564

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$398K$796K2015 Drug cost: $753,812 (USD; Tot_Drug_Cst)2016 Drug cost: $796,099 (USD; Tot_Drug_Cst)2017 Drug cost: $683,657 (USD; Tot_Drug_Cst)2018 Drug cost: $649,696 (USD; Tot_Drug_Cst)2019 Drug cost: $628,809 (USD; Tot_Drug_Cst)2020 Drug cost: $537,840 (USD; Tot_Drug_Cst)2021 Drug cost: $588,502 (USD; Tot_Drug_Cst)2022 Drug cost: $427,204 (USD; Tot_Drug_Cst)2023 Drug cost: $524,667 (USD; Tot_Drug_Cst)2024 Drug cost: $551,420 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151,1739,407$753,812
20161,1169,529$796,099
20179758,283$683,657
20181,0197,863$649,696
20191,1766,228$628,809
20201,0284,190$537,840
20211,0304,016$588,502
20229553,429$427,204
20239983,939$524,667
20241,0104,324$551,420

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system205242$100
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more207300$78
92083Exam of visual field with extended testing315515$57
92250Photography of the retina301308$31
92025Ct scan of cornea266276$30

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost30220,238$182,654
RocklatanNetarsudil Mesylat/Latanoprost673,697$47,732
CombiganBrimonidine Tartrate/Timolol866,079$43,330
VyzultaLatanoprostene Bunod614,267$38,515
SimbrinzaBrinzolamide/Brimonidine Tart634,201$28,146

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$342Johnson & Johnson Surgical Vision, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam J. Lish, MD?

Tedicare shows public-source Medicare data for Adam J. Lish, MD (NPI 1083711766), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam J. Lish, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam J. Lish, MD?

Adam J. Lish, MD is linked to BROOK PLAZA OPTHALMOLOGY ASSOC PC (billing NPI 1093939001) in the available physician profile data.

Does Adam J. Lish, MD have Open Payments data?

Adam J. Lish, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.